Further, the phospho-serine-15 levels of p53 were drastically downregulated in benign and malignant stages of breast cancer (Figure S4A and B) implicating that once SMAR1 function is disrupted, p53 is no more stabilized. The gene discussed is TP53; the disease is breast cancer.